Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Recalcitrant Vulval and Perineal Crohn Disease Responding to Hyperbaric Oxygen Therapy

Meah, Nekma, MBChB1; Subramanian, Sreedhar, MD, MRCP2; Khirwadkar, Nitin, FRCPath3; Cope, Tristan, FRCA, FFICM4; Bell, Hazel, FRCP1

Journal of Lower Genital Tract Disease: October 2018 - Volume 22 - Issue 4 - p 409–411
doi: 10.1097/LGT.0000000000000417
Case Report

Use of hyperbaric oxygen therapy in a case of refractory vulval and perineal Crohn disease.

1Departments of Dermatology, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK;

2Department of Gastroenterology, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK;

3Department of Pathology, The Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK; and

4Hyperbaric Medicine, North West Emergency Recompression Unit, Murrayfield Hospital, Wirral, UK

Correspondence to: Nekma Meah, MBChB, Department of Dermatology, The Royal Liverpool and Broadgreen University Hospitals, Thomas Drive, Liverpool L14 3LB, UK. E-mail: nekma.meah@gmail.com

Financial Funding: None.

Conflict of interest disclosures: S.S. has received speaker fee from MSD, Actavis, AbbVie, Dr. Falk Pharma, and Shire and received educational grant from MSD, AbbVie, and Actavis and is an advisory board member for AbbVie, Dr. Falk Pharma, Janssen, and Vifor Pharma.

Copyright © 2018 by the American Society for Colposcopy and Cervical Pathology